Most cancer drugs are designed to interfere with one or more events in cell proliferation or
survival. As healthy cells may also need to proliferate and avoid apoptosis, anticancer …

Prostate cancer (PCa) is the most common malignancy in men worldwide, leading to
substantial morbidity and mortality. At present, imaging of PCa has become increasingly …

Despite many advances in the past years, the treatment of metastatic prostate cancer still
remains challenging. In recent years, prostate-specific membrane antigen (PSMA) inhibitors …

On the basis of the high and consistent expression of prostate-specific membrane antigen
(PSMA) in metastatic prostate cancer (PC), the goal of this study was the development …

Purpose Prostate-specific membrane antigen (PSMA) is a recognized target for imaging
prostate cancer. Here we present initial safety, biodistribution, and radiation dosimetry …

The prostate-specific membrane antigen (PSMA) is a molecular target whose use has
resulted in some of the most productive work toward imaging and treating prostate cancer …

Background The relevance of prostate-specific membrane antigen (PSMA) targeting in the
clinical management of prostate cancer (PCa) is continually increasing, entailing the …

Magnetic resonance (MR) imaging is advantageous because it concurrently provides
anatomic, functional, and molecular information. MR molecular imaging can combine the …

Prostate-specific membrane antigen (PSMA), a type II glycoprotein, is highly expressed in
almost all prostate cancers. By playing such a universal role in the disease, PSMA provides …

Despite an increasing knowledge about the causes of cancer, this disease is difficult to cure
and still causes far too high a death rate. Based on advances in our understanding of …